🔎︎
New research presented at the American Diabetes Association’s 85th Scientific Sessions challenges the widespread belief that diet beverages are benign for metabolic health. The study, led by Dr. Hamid R. Farshchi, CEO of D2Type and former University of Nottingham associate professor, demonstrates that women with type 2 diabetes who replace diet drinks with water achieve significantly better outcomes.
The 18-month randomized controlled trial followed 81 women with type 2 diabetes and overweight or obesity who regularly consumed diet beverages. Participants completed a six-month weight loss program followed by a 12-month weight maintenance phase. The intervention group substituted their usual diet drinks with water five times weekly after lunch, while the control group continued their regular diet beverage consumption.
The water group demonstrated superior outcomes across multiple metrics. Women assigned to water experienced significantly greater average weight loss compared to the diet beverage group (6.82 kg vs. 4.85 kg). More remarkably, 90% of participants in the water group achieved diabetes remission, compared to 45% in the diet beverage group.
Additional health markers showed consistent improvements in the water group, including better BMI, fasting glucose, insulin levels, insulin resistance, postprandial glucose, and triglycerides.
The findings suggest that approximately one-fifth of Americans who consume diet drinks daily may benefit from this simple substitution. While diet sodas contain no calories, they may affect metabolic processes differently than water. The study provides evidence that the common assumption about diet beverages being metabolically neutral may need reconsideration.
Dr. Farshchi noted that the research supports promoting water as the primary beverage choice rather than simply recommending low-calorie alternatives for diabetes management. The researchers plan to explore broader lifestyle interventions examining how factors like sleep, stress, and physical activity interact with dietary choices.
This preliminary research, presented as a poster session, requires peer-reviewed publication and replication in larger, more diverse populations before definitive clinical recommendations can be established.